The Alpestria-1 study enrolled (in France, USA and Spain) 26 patients with Alport syndrome at high risk of a rapid loss of kidney function despite stable multiple SoC drugs, including ...

The firm began a Phase II study of evorpacept in HER2-positive breast cancer patients and began testing a higher dose of ALX2004 in a separate Phase I trial.

First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...

Making medical policy based on racial stereotypes harmed all Black Americans waiting for a kidney. This lawsuit is brought by ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

Elevated prolactin levels can cause symptoms like irregular periods and nipple discharge. Low prolactin levels are less common and can cause a reduced milk supply in lactating individuals. High ...